Opus Genetics, Inc. (IRD)
4.76
-0.11
(-2.26%)
USD |
NASDAQ |
Sep 25, 16:00
4.765
0.00 (0.00%)
After-Hours: 19:59
Opus Genetics Market Cap : 393.40M for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 393.40M |
| September 24, 2026 | 402.50M |
| September 23, 2026 | 399.19M |
| September 22, 2026 | 426.46M |
| September 21, 2026 | 431.42M |
| September 18, 2026 | 428.12M |
| September 17, 2026 | 436.38M |
| September 16, 2026 | 447.13M |
| September 15, 2026 | 481.01M |
| September 14, 2026 | 493.41M |
| September 11, 2026 | 499.19M |
| September 10, 2026 | 501.67M |
| September 09, 2026 | 473.57M |
| September 08, 2026 | 358.69M |
| September 04, 2026 | 385.97M |
| September 03, 2026 | 380.18M |
| September 02, 2026 | 367.78M |
| September 01, 2026 | 316.54M |
| August 31, 2026 | 299.19M |
| August 28, 2026 | 304.97M |
| August 27, 2026 | 318.19M |
| August 26, 2026 | 314.06M |
| August 25, 2026 | 339.68M |
| August 24, 2026 | 333.07M |
| August 21, 2026 | 334.72M |
| Date | Value |
|---|---|
| August 20, 2026 | 340.51M |
| August 19, 2026 | 336.38M |
| August 18, 2026 | 304.97M |
| August 17, 2026 | 301.66M |
| August 14, 2026 | 298.36M |
| August 13, 2026 | 307.45M |
| August 12, 2026 | 310.76M |
| August 11, 2026 | 320.67M |
| August 10, 2026 | 302.49M |
| August 07, 2026 | 302.49M |
| August 06, 2026 | 307.45M |
| August 05, 2026 | 312.41M |
| August 04, 2026 | 306.62M |
| August 03, 2026 | 259.91M |
| July 31, 2026 | 264.90M |
| July 30, 2026 | 274.19M |
| July 29, 2026 | 247.77M |
| July 28, 2026 | 243.48M |
| July 27, 2026 | 239.20M |
| July 24, 2026 | 219.92M |
| July 23, 2026 | 208.50M |
| July 22, 2026 | 217.78M |
| July 21, 2026 | 218.49M |
| July 20, 2026 | 217.78M |
| July 17, 2026 | 233.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Faeth Therapeutics, Inc. | 723.32M |
| Perspective Therapeutics, Inc. | 287.50M |
| Rezolute, Inc. | 375.98M |
| Praxis Precision Medicines, Inc. | 7.838B |
| Nuvectis Pharma, Inc. | 539.77M |
Market Cap Related Metrics
| PS Ratio | 40.91 |
| Price | 4.76 |
| Earnings Yield | -28.92% |